Prognostic Value of Genomic Analysis after Neoadjuvant Chemotherapy for Breast Cancer

被引：0
|
作者：
Mayer, E. L.
Shak, S.
Miller, K.
Rugo, H.
Carey, L.
Ryabin, N.
Pomeroy, C.
Yoshizawa, C.
Winer, E. P.
Burstein, H. J.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Genom Hlth Inc, Redwood City, CA USA
[3] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P3-10-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-10-13
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic value of subtype changes after neoadjuvant chemotherapy in primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Yoshikawa, Mio
    Jinno, Hiromitsu
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Ozdemir, Ozlem
    Zengel, Baha
    Cavdar, Demet Kocatepe
    Yilmaz, Cengiz
    Durusoy, Raika
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (02) : 167 - 171
  • [3] Clinical significance and prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients
    He, Yang
    Zhang, Jing
    Chen, Hui
    Zhou, Ying
    Hong, Liping
    Ma, Yue
    Chen, Nannan
    Zhao, Weipeng
    Tong, Zhongsheng
    [J]. FRONTIERS IN SURGERY, 2023, 9
  • [4] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    J-Y Pierga
    E Mouret
    V Diéras
    V Laurence
    P Beuzeboc
    T Dorval
    T Palangié
    M Jouve
    A Vincent-Salomon
    S Scholl
    J-M Extra
    B Asselain
    P Pouillart
    [J]. British Journal of Cancer, 2000, 83 : 1480 - 1487
  • [5] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    Pierga, JY
    Mouret, E
    Diéras, V
    Laurence, V
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Vincent-Salomon, A
    Scholl, S
    Extra, JM
    Asselain, B
    Pouillart, P
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1480 - 1487
  • [6] Prognostication of genomic characteristics of residual breast cancer after neoadjuvant chemotherapy
    Kim, Ji-Yeon
    Park, Sabin
    Ahn, Sepil
    Seo, Eun Seop
    Kim, Soyeon
    Gregory, Mark
    Killingbeck, Emily
    Cho, Eun Yoon
    Lee, Jeong Eon
    Ahn, Jin Seok
    Park, Yeon Hee
    Park, Woong-Yang
    Kim, Hoon
    Lee, Semin
    Im, Young-Hyuck
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [7] Genomic profiling of residual tumor after neoadjuvant chemotherapy for breast cancer
    Hattori, Masaya
    Rajagopal, Padma Sheila
    Sveen, Lise
    Khramtsova, Galina
    Yoshimatsu, Toshio
    Beaubier, Nike
    Barber, Mathew
    Abboushi, Taylor
    Fang, Liu
    Zheng, Yonglan
    White, Kevin
    Huo, Dezheng
    Olopade, Olufunmilayo I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Prognostic value of residual cancer burden and Miller-Payne system after neoadjuvant chemotherapy for breast cancer
    Wang, Wei
    Liu, Yinhua
    Zhang, Hong
    Zhang, Shuang
    Duan, Xuening
    Ye, Jingming
    Xu, Ling
    Zhao, Jianxin
    Cheng, Yuanjia
    Liu, Qian
    [J]. GLAND SURGERY, 2021, 10 (12) : 3211 - +
  • [9] The prognostic value of FDG response after two cycles of neoadjuvant chemotherapy in triple negative breast cancer
    Groheux, D.
    Hindie, E.
    Giacchetti, S.
    Delord, M.
    Hamy, A.
    de Roquancourt, A.
    Vercellino, L.
    Berenger, N.
    Marty, M.
    Espie, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S217 - S217
  • [10] Prognostic Value at 4 Years of FDG PET, after the First Course of Neoadjuvant Chemotherapy in Breast Cancer
    Humbert, O.
    Berriolo-Riedinger, A.
    Arnoud, L.
    Coudert, B.
    Toubeau, M.
    Dygai-Cochet, I.
    Cochet, A.
    Mayer, F.
    Fumoleau, P.
    Brunotte, F.
    [J]. CANCER RESEARCH, 2010, 70
12345